company coverage
Lakefront Biotherapeutics NV research (EURONEXT-AMSTERDAM:LKFT)
Coverage of Lakefront Biotherapeutics NV collects dated research on business quality, return drivers, balance-sheet resilience, valuation scenarios, and what would change the thesis for EURONEXT-AMSTERDAM:LKFT.
1 edition linked in this hub.
Coverage
- 12 Aug 2026Lakefront's first results after Ouro put €734 million behind two published autoimmune patientsLakefront Biotherapeutics (EURONEXT-AMSTERDAM:LKFT) rose 3.84% after H1 results. We trace what €734 million bought and what its cash still covers.